JAMA Ophthalmology : Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy
- Author
- American Medical Association, 2017
- Published
- Thu 07 Aug 2025
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamaophthalmol.2025.2758
Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD.
Related Content:
